| Literature DB >> 30200926 |
Lauren R Hepworth1, Fiona J Rowe2.
Abstract
BACKGROUND: Visual field loss occurs frequently in neurological conditions and perimetry is commonly requested for patients with suspected or known conditions. There are currently no guidelines for how visual fields in neurological conditions should be assessed. There is a wide range of visual field programs available and the wrong choice of program can potentially fail to detect visual field loss. We report the results of a systematic review of the existing evidence base for the patterns of visual field loss in four common neurological conditions and the perimetry programs used, to aid the design of future research and clinical practice guidelines.Entities:
Keywords: Chiasmal compression; Idiopathic intracranial hypertension; Optic neuropathy; Perimetry; Stroke; Visual field loss
Mesh:
Year: 2018 PMID: 30200926 PMCID: PMC6131852 DOI: 10.1186/s12886-018-0912-1
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Search terms
| OR | OR |
|---|---|
| AND | |
| Pituitary | Visual Fields |
| Pituitary adenoma | Vision Disorders |
| Craniopharyngioma | Vision |
| Pseudotumour cerebri | Visual field loss |
| Idiopathic intracranial hypertension | Visual field defect |
| Benign intracranial hypertension | Perimetry |
| Chiasm | Perimeter |
| Stroke | Visual field assessment |
| Cerebrovascular disorders | Humphrey™ |
| Brain ischaemia | Octopus™ |
| Intracranial Haemorrhage | |
| Optic neuropathy | |
| Anterior ischaemic optic neuropathy | |
| Multiple sclerosis | |
| Optic neuritis | |
| Demyelination | |
| Neuromyelitis optica | |
| Devic’s disease | |
| Compressive neuropathy | |
| Toxic neuropathy |
™ Humphrey (Carl Zeiss AG, Germany), Octopus (Haag Streit International, Switzerland)
Fig. 1Flowchart of pathway for inclusion of articles
Number of most commonly reported perimeters and programmes used for the four neurological conditions of interest, including if more detail on programme was specified or not. ™ Humphrey (Zeiss Meditec, USA), Octopus (Haag Streit International, Switzerland)
| n= | Neurological condition | ||||
|---|---|---|---|---|---|
| Idiopathic intracranial hypertension | Optic Neuropathy | Chiasmal compression | Stroke | ||
| Perimeter used | Multiple | 26 | 27 | 31 | 5 |
| Humphrey | 38 | 86 | 60 | 11 | |
| 10 unspecified | 5 unspecified | 7 unspecified | 3 unspecified | ||
| Humphrey | 16 | 46 | 20 | 4 | |
| 6 unspecified | 22 unspecified | 10 unspecified | 0 unspecified | ||
| Humphrey | 14 | 39 | 22 | 5 | |
| 7 unspecified | 11 unspecified | 5 unspecified | 1 unspecified | ||
| Goldmann | 22 | 31 | 41 | 8 | |
| 18 unspecified | 30 unspecified | 41 unspecified | 7 unspecified | ||
| Octopus | 6 | 9 | 9 | 1 | |
| 6 unspecified | 1 unspecified | 2 unspecified | 1 unspecified | ||
Fig. 2Percentage of reported patterns of visual field loss in the four neurological conditions of interest